Trial news

We have reached 219 participants screened and 165 randomised!

We have reached 187 participants screened and 135 randomised!

On the 29th of November 2023, at the MS Research conference in Perth, Australia, it was announced that people with progressive MS in Australia will be able to join Platypus (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis). Platypus is an extension of Octopus and is funded by MS Western Australia and MS Australia. For more information, visi ...

A four-part series about the Octopus trial has been produced by the Trial Talk podcast at the MRC Clinical Trials Unit at UCL. The episodes explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS. You can listen to the episodes in SoundCloud, Spotify, Google podcasts and Apple podcasts. ...

As previously reported in February by Susan Scott, one of our patient representatives, Octopus had a presence at the International Advisory Committee meeting on Clinical Trials in MS in Toronto in December 2022. Following this meeting, a publication has been drafted and published on Participant involvement in Octopus.  This is alongside four further publications published foll ...

Octopus is funded by the MS Society